Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2016. Start Trial.
Date Value
October 02, 2026 1.746
October 01, 2026 1.863
September 30, 2026 1.944
September 29, 2026 1.896
September 28, 2026 1.948
September 25, 2026 1.865
September 24, 2026 1.874
September 23, 2026 1.911
September 22, 2026 2.129
September 21, 2026 2.115
September 18, 2026 2.143
September 17, 2026 2.209
September 16, 2026 2.146
September 15, 2026 2.148
September 14, 2026 2.349
September 11, 2026 2.370
September 10, 2026 2.376
September 09, 2026 2.421
September 08, 2026 2.474
September 04, 2026 2.465
September 03, 2026 2.419
September 02, 2026 2.504
September 01, 2026 2.393
August 31, 2026 2.366
August 28, 2026 2.425
Date Value
August 27, 2026 2.463
August 26, 2026 2.504
August 25, 2026 2.532
August 24, 2026 2.471
August 21, 2026 2.621
August 20, 2026 2.530
August 19, 2026 2.602
August 18, 2026 2.504
August 17, 2026 2.541
August 14, 2026 2.442
August 13, 2026 2.442
August 12, 2026 2.399
August 11, 2026 2.621
August 10, 2026 2.679
August 07, 2026 2.650
August 06, 2026 2.553
August 05, 2026 2.467
August 04, 2026 2.434
August 03, 2026 2.362
July 31, 2026 2.277
July 30, 2026 2.306
July 29, 2026 2.343
July 28, 2026 2.312
July 27, 2026 2.252
July 24, 2026 2.230

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 2.628
Alnylam Pharmaceuticals, Inc. 21.70
Savara, Inc. 6.877
Vericel Corp. 5.552
Biogen, Inc. 1.723

Price to Book Value Related Metrics

Price 8.98
Earnings Yield -12.11%
Market Cap 309.06M